Back to top
Ocrevus (ocrelizumab) Injection, 300 mg/10 mL
Ocrevus (ocrelizumab) Injection, 300 mg/10 mL

Ocrevus (ocrelizumab) Injection, 300 mg/10 mL

Price 2365.0 USD ($)/ vial

Ocrevus (ocrelizumab) Injection, 300 mg/10 mL Specification

  • Salt Composition
  • Ocrelizumab 300 mg/10 mL (30 mg/mL) injection
  • Dosage Form
  • Injection
  • Origin
  • India
  • Indication
  • Treatment of multiple sclerosis (MS).
  • Enzyme Types
  • Other
  • Ingredients
  • Other
 
 

About Ocrevus (ocrelizumab) Injection, 300 mg/10 mL

Ocrevus Injection 300 mg/10 mL (Ocrelizumab)

Ocrevus is a prescription medicine containing ocrelizumab, a CD20-directed monoclonal antibody. The pack shown contains one single-dose vial with 300 mg in 10 mL (30 mg/mL) for intravenous infusion after dilution. www.accessdata.fda.gov

Uses

Ocrevus is used to treat certain forms of multiple sclerosis (MS):

  • Relapsing forms of MS in adults
  • Primary progressive MS in adults
  • Relapsing-remitting MS in eligible children aged 10 years and older who weigh at least 25 kg

Approved uses may vary by country. www.accessdata.fda.gov

Benefits

Ocrevus can help control MS disease activity. Clinical studies found fewer relapses in people with relapsing MS and slower disability progression in some adults with primary progressive MS. Individual results vary, and Ocrevus is not a cure for MS. www.accessdata.fda.gov

How It Works

Ocrelizumab targets CD20, a protein found on certain B cells. By reducing these cells, it is thought to help limit immune activity involved in MS. www.accessdata.fda.gov

How to Use

  • Ocrevus is diluted and given into a vein by a qualified healthcare professional.
  • The clinician determines the dose and schedule.
  • Patients are monitored during and after the infusion. Do not self-administer or change the treatment schedule. www.accessdata.fda.gov

Possible Side Effects

Common side effects include:

  • Infusion reactions
  • Upper respiratory tract infections

Infusion reactions may include itching, rash, flushing, headache, dizziness, nausea, or breathing difficulty. Serious infections and other significant risks may also occur. Contact a healthcare professional promptly about concerning symptoms. www.accessdata.fda.gov

Safety Advice

  • Tell your healthcare professional about current or recent infections, hepatitis B, liver problems, vaccinations, and other medicines.
  • Ocrevus is contraindicated in active hepatitis B infection and in people with a history of a life-threatening infusion reaction to Ocrevus.
  • Infusion reactions can occur during treatment or up to 24 hours afterward. www.accessdata.fda.gov

Quick Tips

  • Store unopened vials at 2C to 8C in the outer carton to protect from light.
  • Do not freeze or shake.
  • Keep scheduled infusion appointments. If an infusion is missed, contact the healthcare provider for guidance. www.accessdata.fda.gov

Frequently Asked Questions

Does Ocrevus cure multiple sclerosis?
No. Ocrevus is a treatment that can help control MS disease activity; it is not a cure.

How is Ocrevus given?
It is given as a diluted intravenous infusion by a healthcare professional, with monitoring during and after treatment. www.accessdata.fda.gov

How often is Ocrevus given?
The treatment schedule depends on the patient and the prescribing clinicians instructions. Follow the schedule provided by the treating healthcare professional.

What checks may be needed before treatment?
The healthcare team may check for hepatitis B, infection, liver problems, and immunoglobulin levels, and review vaccination status. www.accessdata.fda.gov

Can I receive vaccines while using Ocrevus?
Ask your healthcare professional before receiving any vaccine. Live or live-attenuated vaccines are not recommended during treatment and until B-cell recovery. www.accessdata.fda.gov

What should I do if I develop an infection?
Contact your healthcare professional and tell them about your symptoms before your next infusion. An infusion may be delayed if you have an active infection. www.accessdata.fda.gov

When can an infusion reaction happen?
It may occur during the infusion or up to 24 hours afterward. Report symptoms such as rash, itching, flushing, dizziness, or breathing difficulty to a healthcare professional promptly. www.accessdata.fda.gov

What if I miss an infusion appointment?
Contact your healthcare provider as soon as possible to arrange guidance. Do not change the schedule yourself. www.accessdata.fda.gov

Can Ocrevus be used during pregnancy or breastfeeding?
Discuss pregnancy, plans for pregnancy, or breastfeeding with your healthcare professional before treatment. The prescribing information notes that there are limited data on use during pregnancy and breastfeeding. 


Product Enquiries

Contact GlobMed India for product availability and export enquiries. Supply is subject to prescription requirements and applicable local regulations.

Disclaimer

This content is for general product information only and does not replace the official prescribing information or advice from a qualified healthcare professional. Use Ocrevus only under medical supervision.


Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anticancer Injection Category

Bevacizumab Concentrate For Injection

Bevacizumab Concentrate For Injection

Minimum Order Quantity : 10 Vials

Ingredients : Other , Bevacizumab 400 mg/16 mL; excipients

Storage Instructions : Store in a refrigerator (2C 8C). Do not freeze. Protect from light.

Salt Composition : Bevacizumab

Indication : Used in the treatment of various cancers such as colorectal cancer, lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer

400mg Bevacizumab Injection

400mg Bevacizumab Injection

Minimum Order Quantity : 10 Vials

Ingredients : Other , Bevacizumab and excipients

Storage Instructions : Store in a refrigerator (2C to 8C). Do not freeze.

Salt Composition : Bevacizumab (rDNA Origin)

Indication : For use in treatment of certain types of cancer via intravenous (I.V.) infusion

450mg Carboplatin Injection IP

450mg Carboplatin Injection IP

Price 1832 INR / Vial

Minimum Order Quantity : 10 Vials

Ingredients : Other , Carboplatin

Storage Instructions : Store below 25C

Salt Composition : Carboplatin 450mg

Indication : Ovarian cancer and small cell lung cancer

Trastuzumab For Injection

Trastuzumab For Injection

Price 5500 INR / Vial

Minimum Order Quantity : 10 Vials

Ingredients : Other , Trastuzumab lyophilized powder

Storage Instructions : Store at 28C, refrigerate

Salt Composition : Trastuzumab 440mg (rDNA origin)

Indication : Breast cancer and Stomach cancer



GLOBMED INDIA
GST : 27CBCPD6646J1ZJ trusted seller